Cargando…
Epigenetic Mechanisms as Emerging Therapeutic Targets and Microfluidic Chips Application in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a disease that progress over time and is defined as an increase in pulmonary arterial pressure and pulmonary vascular resistance that frequently leads to right-ventricular (RV) failure and death. Epigenetic modifications comprising DNA methylation, histone re...
Autores principales: | Ho, Linh, Hossen, Nazir, Nguyen, Trieu, Vo, Au, Ahsan, Fakhrul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773438/ https://www.ncbi.nlm.nih.gov/pubmed/35052850 http://dx.doi.org/10.3390/biomedicines10010170 |
Ejemplares similares
-
A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
por: Sarkar, Tanoy, et al.
Publicado: (2022) -
Multicellular Cell Seeding on a Chip: New Design and Optimization towards Commercialization
por: Nguyen, Trieu, et al.
Publicado: (2022) -
3D Printing in Solid Dosage Forms and Organ-on-Chip Applications
por: Kassem, Tarek, et al.
Publicado: (2022) -
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
por: Al-Hilal, Taslim A., et al.
Publicado: (2020) -
Catheterization of Pulmonary and Carotid Arteries for Concurrent Measurement of Mean Pulmonary and Systemic Arterial Pressure in Rat Models of Pulmonary Arterial Hypertension
por: Sarkar, Tanoy, et al.
Publicado: (2023)